PTCA catheter BIOSTREAM™

coronaryballoonhydrophilic

Designed for in-stent restenosis: The use of the BioStream™ PTCA catheter is indicated for patients with discrete lesions of the coronary arteries with a reference vessel diameter of 1.50 to 4.00 mm for the purpose of improving the coronary lumen diameter. The BioStream™ PTCA catheter is indicated for the dilatation of the affected segments of a coronary artery or a coronary bypass in order to enhance myocardial perfusion. The BioStream paclitaxel eluting coronary balloon catheter is especially indicated for the treatment of coronary in-stent restenosis. The treatment process With balloon dilatation, the injuries to the arterial wall initiate an inflammatory reaction with an excretion of growth factors which trigger the onset of cell division and smooth muscle cell migration. Paclitaxel prevents restenosis by stabilizing microtubal formation and thus prevents the cells going through the phases of replication, resulting in the inhibition of cell division. Paclitaxel reduces the excretion of the platelet-derived growth factor (PDGF) that mediates vascular smooth muscle cell migration to the intima. BioStream™: Thee right choice > BioStream offers excellent pushability, trackability and crossability due to its low balloon profile, low tip entry profile and the hydrophilic coating on the distal shaft of the catheter. > BioStream with the shellac and paclitaxel coating and its 3-fold balloon design, enables delivery of the drug without worry of dissolution in transit, to where it matters most - across the lesion3. > For in-stent restenosis BioStream delivers the designated dose of paclitaxel and leaves nothing behind.